A new bill, the Sentinel Assurance for Effective Devices (SAED) Act of 2012, introduced by the House of Representatives last month “will allow FDA to more regularly collect, review, and trend adverse event data for medical devices,” according to an article on the FDA Law Blog website by Jennifer D. Newberger. Drug companies have been doing this for years, and now that may be expanding to include medical device companies as well.
To read the article mentioned above, click here, or check out this article on the subject.
If you need help with your post marketing regulatory submissions, contact Pearl here.